118 related articles for article (PubMed ID: 8121720)
1. [Lymphocyte hybridization and cancerology: diagnostic and therapeutic applications. Example of tumor markers].
Cazin JL; Gosselin P; Demaille A
Pathol Biol (Paris); 1993 Nov; 41(9):881-6. PubMed ID: 8121720
[TBL] [Abstract][Full Text] [Related]
2. Monoclonal antibodies.
Ackermann R
Hum Cell; 1988 Mar; 1(1):46-53. PubMed ID: 3154013
[TBL] [Abstract][Full Text] [Related]
3. Tumor markers as targets for selective diagnostic and therapeutic procedures.
Roselli M; Guadagni F; Buonomo O; Belardi A; Ferroni P; Diodati A; Anselmi D; Cipriani C; Casciani CU; Greiner J; Schlom J
Anticancer Res; 1996; 16(4B):2187-92. PubMed ID: 8694541
[TBL] [Abstract][Full Text] [Related]
4. [Monoclonal antibodies in research and clinical medicine].
Voigt A
Kinderarztl Prax; 1989 Oct; 57(10):479-87. PubMed ID: 2689756
[TBL] [Abstract][Full Text] [Related]
5. Optimizing bispecific antibody pretargeting for use in radioimmunotherapy.
Sharkey RM; Karacay H; Richel H; McBride WJ; Rossi EA; Chang K; Yeldell D; Griffiths GL; Hansen HJ; Goldenberg DM
Clin Cancer Res; 2003 Sep; 9(10 Pt 2):3897S-913S. PubMed ID: 14506188
[TBL] [Abstract][Full Text] [Related]
6. Target therapy of cancer: implementation of monoclonal antibodies and nanobodies.
Majidi J; Barar J; Baradaran B; Abdolalizadeh J; Omidi Y
Hum Antibodies; 2009; 18(3):81-100. PubMed ID: 19729803
[TBL] [Abstract][Full Text] [Related]
7. Recent progress in the use of monoclonal antibodies for imaging and therapy.
Monson JR
Curr Opin Gen Surg; 1993; ():334-9. PubMed ID: 7584004
[TBL] [Abstract][Full Text] [Related]
8. [Importance of monoclonal antibodies in the analysis of tumor markers].
Bohuon C; Bellet D; Bidart JM; Comoy E
Bull Acad Natl Med; 1991; 175(6):885-92; discussion 892-3. PubMed ID: 1742627
[TBL] [Abstract][Full Text] [Related]
9. [Monoclonal antibodies. General approach and radioimmunotherapy].
Sousa O; Vieira E
Acta Med Port; 1998 Apr; 11(4):337-47. PubMed ID: 9644845
[TBL] [Abstract][Full Text] [Related]
10. Radioimmunotherapy of human colon cancer xenografts using a dimeric single-chain Fv antibody construct.
Pavlinkova G; Booth BJ; Batra SK; Colcher D
Clin Cancer Res; 1999 Sep; 5(9):2613-9. PubMed ID: 10499640
[TBL] [Abstract][Full Text] [Related]
11. Novel approaches to tumor detection and therapy using a combination of monoclonal antibody and cytokine.
Greiner JW; Guadagni F; Roselli M; Nieroda CA
Anticancer Res; 1996; 16(4B):2129-33. PubMed ID: 8694532
[TBL] [Abstract][Full Text] [Related]
12. Pharmacokinetics and biodistribution of genetically-engineered antibodies.
Colcher D; Pavlinkova G; Beresford G; Booth BJ; Choudhury A; Batra SK
Q J Nucl Med; 1998 Dec; 42(4):225-41. PubMed ID: 9973838
[TBL] [Abstract][Full Text] [Related]
13. [Systemic radiotherapy using monoclonal antibodies. Options and problems].
Sautter-Bihl ML; Wannenmacher M; Bihl H
Strahlenther Onkol; 1993 Jun; 169(6):358-65. PubMed ID: 8316939
[TBL] [Abstract][Full Text] [Related]
14. High-linear energy transfer (LET) alpha versus low-LET beta emitters in radioimmunotherapy of solid tumors: therapeutic efficacy and dose-limiting toxicity of 213Bi- versus 90Y-labeled CO17-1A Fab' fragments in a human colonic cancer model.
Behr TM; Béhé M; Stabin MG; Wehrmann E; Apostolidis C; Molinet R; Strutz F; Fayyazi A; Wieland E; Gratz S; Koch L; Goldenberg DM; Becker W
Cancer Res; 1999 Jun; 59(11):2635-43. PubMed ID: 10363986
[TBL] [Abstract][Full Text] [Related]
15. The application of monoclonal antibodies in the cytologic evaluation of tumors.
Szpak C; McLendon RE; Simpson JF; Thor A; Johnston WW
Clin Lab Med; 1990 Mar; 10(1):77-103. PubMed ID: 2184981
[TBL] [Abstract][Full Text] [Related]
16. Possible applications of antibodies or their genes in cancer therapy.
Kuroki M; Huang J; Shibaguchi H; Tanaka T; Zhao J; Luo N; Hachimine K; Kinugasa T; Maekawa S; Enatsu S; Hamanaka W; Fukami T; Kuroki M
Anticancer Res; 2006; 26(6A):4019-25. PubMed ID: 17195452
[TBL] [Abstract][Full Text] [Related]
17. Fractionated radioimmunotherapy of intraperitoneally growing ovarian cancer in nude mice with 211At-MX35 F(ab')2: therapeutic efficacy and myelotoxicity.
Elgqvist J; Andersson H; Bäck T; Claesson I; Hultborn R; Jensen H; Lindegren S; Olsson M; Palm S; Warnhammar E; Jacobsson L
Nucl Med Biol; 2006 Nov; 33(8):1065-72. PubMed ID: 17127181
[TBL] [Abstract][Full Text] [Related]
18. [The diagnostic value and therapeutic perspectives of monoclonal antibodies in bronchopulmonary cancer].
Desrues B; Dazord L; Delaval P; Bourguet P; Ramée MP; Thoreux PH
Rev Mal Respir; 1991; 8(4):327-38. PubMed ID: 1924969
[TBL] [Abstract][Full Text] [Related]
19. What's new in cancer monitoring?
Matzku S
Pathol Res Pract; 1987 Oct; 182(5):699-703. PubMed ID: 3317325
[TBL] [Abstract][Full Text] [Related]
20. Therapeutic efficacy and tumor dose estimations in radioimmunotherapy of intraperitoneally growing OVCAR-3 cells in nude mice with (211)At-labeled monoclonal antibody MX35.
Elgqvist J; Andersson H; Bäck T; Hultborn R; Jensen H; Karlsson B; Lindegren S; Palm S; Warnhammar E; Jacobsson L
J Nucl Med; 2005 Nov; 46(11):1907-15. PubMed ID: 16269606
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
